Search For Lab Tests Here

The Cardio IQ™ Insulin Resistance Panel with Score Test measures markers of insulin resistance to evaluate glucose control, lipid metabolism, and cardiometabolic health. The score offers insight into type 2 diabetes risk, cardiovascular disease, and endocrine balance. This test supports monitoring of metabolic function, energy regulation, and systemic conditions tied to insulin resistance.

The Suspected Insulin Resistance panel is a diagnostic assessment that includes markers such as Glucose, Hemoglobin A1c (HbA1c), and Insulin. This panel is ordered to evaluate insulin resistance, a condition where the body's cells do not respond effectively to insulin, leading to elevated blood glucose levels. Insulin resistance is often associated with prediabetes, type 2 diabetes, and metabolic syndrome.

Assess insulin resistance with the HOMA-IR Calculation Panel, which combines fasting glucose and insulin levels to estimate metabolic function. This panel supports early detection of insulin resistance and helps guide personalized health and wellness strategies.

Panel provides Fasting Glucose and Fasting Insulin results. To calculate HOMA-IR, multiply both results together and then divide by 405.

Evaluate metabolic health and insulin sensitivity with the Visceral Fat and Insulin Resistance Panel. This panel includes glucose, insulin, lipid, inflammation, and liver markers to provide insight into visceral fat related metabolic function, energy regulation, and cardiometabolic risk factors.

The Cardio IQ™ Insulin Test measures fasting insulin levels in the blood to help evaluate insulin resistance, metabolic health, and risk for conditions like type 2 diabetes and cardiovascular disease. It provides insight into how the body regulates blood sugar and supports personalized risk assessment and treatment planning.

The Insulin Test measures insulin levels in blood to assess how the body regulates glucose and metabolism. It helps diagnose insulin resistance, hypoglycemia, type 2 diabetes, and metabolic syndrome. Doctors also use it to evaluate pancreatic function and monitor treatment effectiveness. Frequently ordered with glucose testing, the insulin test provides critical insight into endocrine health, blood sugar control, and risk for diabetes-related complications.

The Triglyceride Driver Identification Panel combines triglycerides with apolipoprotein C-III testing to reveal not just elevated fat levels, but the underlying regulatory drivers. By identifying impaired triglyceride breakdown and clearance, this advanced blood panel provides deeper insight into cardiometabolic risk beyond standard lipid testing and supports more precise evaluation of persistent or unexplained triglyceride elevation.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The Insulin and Glucose panel is a focused diagnostic tool used to evaluate blood sugar levels and insulin, the hormone responsible for regulating glucose uptake from the bloodstream into the cells. This panel includes two essential tests: one for measuring glucose levels and another for assessing insulin levels in the blood. Together, these tests provide valuable insights into the body's glucose metabolism and insulin function, which are crucial for diagnosing and managing diabetes and other metabolic disorders.

 The Diabetes Prevention Program (DPP) Screening Panel is a critical tool in the early identification and management of prediabetes and diabetes. This panel utilizes targeted tests to evaluate an individual's blood sugar levels and their body's ability to process glucose over time. By accurately assessing these factors, the panel helps healthcare providers detect early signs of glycemic control issues, enabling timely intervention that can prevent the onset of diabetes or manage it effectively in its initial stages.

 The Hemoglobin A1c and Glucose panel is a combination of two essential blood tests that provide valuable information about an individual's blood sugar levels over both short and extended periods. This panel helps healthcare professionals assess how well a person's blood sugar is being managed and can indicate the risk or presence of diabetes.

A focused women’s vascular inflammation panel evaluating hs-CRP, LP-PLA2, MPO antibodies, Galectin-3, NT-proBNP, glucose, and insulin. Designed to assess inflammatory signaling, endothelial dysfunction, microvascular risk, metabolic patterns, and cardiac stress beyond traditional cholesterol testing for a more complete view of vascular health.

The Adiponectin Test measures adiponectin, a hormone made by fat cells that helps regulate glucose levels and fatty acid breakdown. Low adiponectin is linked to insulin resistance, type 2 diabetes, obesity, and cardiovascular disease. Doctors use this test to evaluate metabolic health, assess risk for diabetes or heart disease, and monitor patients with weight-related or endocrine disorders. Results help guide prevention and treatment strategies.

The Cardio IQ® Glucose test is a specialized diagnostic test designed to assess blood glucose levels with high precision and accuracy. This test is used to evaluate an individual's metabolic health by measuring glucose concentrations in the blood, providing insight into carbohydrate metabolism, insulin function, and overall glycemic control. Maintaining stable glucose levels is crucial for energy production, cellular function, and preventing metabolic disorders. The Cardio IQ® Glucose test is particularly valuable in assessing the risk of diabetes, prediabetes, insulin resistance, and other metabolic conditions that impact cardiovascular health.

The Insulin Response to Glucose Test, 4 Specimens evaluates insulin secretion and glucose regulation using fasting and three post-glucose solution samples. This expanded view highlights beta-cell activity, insulin resistance, and abnormal carbohydrate metabolism. Results reveal how efficiently the body processes glucose and help identify metabolic dysfunction, prediabetes, and diabetes-related risks.

The Leptin Test measures leptin hormone levels in blood to evaluate metabolism, appetite regulation, and body fat balance. Abnormal levels may indicate obesity, metabolic syndrome, insulin resistance, or leptin deficiency. Doctors use this test to assess unexplained weight gain, difficulty losing weight, or potential endocrine disorders. It also supports research on energy balance, fertility, and overall metabolic health management.

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.